These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12029206)

  • 1. Systolic and diastolic cardiac dysfunction early after the initiation of doxorubicin therapy: significance of gender and concurrent mediastinal radiation.
    Clements IP; Davis BJ; Wiseman GA
    Nucl Med Commun; 2002 Jun; 23(6):521-7. PubMed ID: 12029206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right ventricular myocardial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction.
    Morris DA; Gailani M; Vaz Pérez A; Blaschke F; Dietz R; Haverkamp W; Özcelik C
    J Am Soc Echocardiogr; 2011 Aug; 24(8):886-97. PubMed ID: 21601421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial systolic and diastolic consequences of left ventricular mechanical dyssynchrony in heart failure with normal left ventricular ejection fraction.
    Morris DA; Vaz Pérez A; Blaschke F; Eichstädt H; Ozcelik C; Haverkamp W
    Eur Heart J Cardiovasc Imaging; 2012 Jul; 13(7):556-67. PubMed ID: 22383372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
    Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
    J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial systolic and diastolic performance derived by 2-dimensional speckle tracking echocardiography in heart failure with normal left ventricular ejection fraction.
    Morris DA; Boldt LH; Eichstädt H; Ozcelik C; Haverkamp W
    Circ Heart Fail; 2012 Sep; 5(5):610-20. PubMed ID: 22874137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular diastolic function in patients with left ventricular systolic dysfunction due to coronary artery disease and effect of nicardipine.
    Aroney CN; Semigran MJ; Dec GW; Boucher CA; Fifer MA
    Am J Cardiol; 1991 Apr; 67(9):823-9. PubMed ID: 2011984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wall stress determines systolic and diastolic function--Characteristics of heart failure.
    Alter P; Koczulla AR; Nell C; Figiel JH; Vogelmeier CF; Rominger MB
    Int J Cardiol; 2016 Jan; 202():685-93. PubMed ID: 26454537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.
    Bonow RO; Rosing DR; Bacharach SL; Green MV; Kent KM; Lipson LC; Maron BJ; Leon MB; Epstein SE
    Circulation; 1981 Oct; 64(4):787-96. PubMed ID: 7196813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction.
    Morris DA; Gailani M; Vaz Pérez A; Blaschke F; Dietz R; Haverkamp W; Ozcelik C
    J Am Soc Echocardiogr; 2011 Jun; 24(6):651-62. PubMed ID: 21458230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiography.
    Cottin Y; Touzery C; Dalloz F; Coudert B; Toubeau M; Riedinger A; Louis P; Wolf JE; Brunotte F
    Clin Cardiol; 1998 Sep; 21(9):665-70. PubMed ID: 9755384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans.
    Stoddard MF; Seeger J; Liddell NE; Hadley TJ; Sullivan DM; Kupersmith J
    J Am Coll Cardiol; 1992 Jul; 20(1):62-9. PubMed ID: 1607540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular filling after long-term angiotensin converting enzyme inhibition in congestive heart failure.
    Baur LH; Schipperheyn JJ; Cats VM; van der Wall EE; Baan J; van Dijk AD; Bruschke AV
    Eur Heart J; 1992 Nov; 13 Suppl E():52-6. PubMed ID: 1478210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer.
    Pongprot Y; Sittiwangkul R; Charoenkwan P; Silvilairat S
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):589-95. PubMed ID: 23018571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance.
    Starling MR
    Am Heart J; 1994 Jul; 128(1):124-33. PubMed ID: 8017265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular function in patients with toxic cardiomyopathy and with idiopathic dilated cardiomyopathy treated with Doxorubicin.
    Katamadze NA; Lartsuliani KP; Kiknadze MP
    Georgian Med News; 2009 Jan; (166):43-8. PubMed ID: 19202217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restrictive left ventricular filling patterns are predictive of diastolic ventricular interaction in chronic heart failure.
    Atherton JJ; Moore TD; Thomson HL; Frenneaux MP
    J Am Coll Cardiol; 1998 Feb; 31(2):413-8. PubMed ID: 9462587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a novel inotropic agent (OPC-18790) on systolic and diastolic function in patients with severe heart failure.
    Hoit BD; Burwig S; Eppert D; Bhat G; Walsh RA
    Am Heart J; 1994 Dec; 128(6 Pt 1):1156-63. PubMed ID: 7985596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.